FDA moves toward easing restrictions on certain peptides BioPharma Dive Peptides and BPC 157 for Pain: PainExam Podcast Apple Podcasts FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides After Peptide Sciences Renew Vitality